(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

NATPARA: Lyophilisate for solution for injection (25mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PARATHYROID HORMONE (para THI roid) is used to increase calcium levels in patients with low amounts of parathyroid hormone.

In-Depth Information

NATPARA 25mcg Powder for Injection

NDC: 688750202
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypoparathyroidism, Hypocalcemia

Storage Information
Avoid exposure to heat
Refrigerate (between 36 and 46 degrees F)
Protect from light
Discard any unused reconstituted product after 14 days
Do not use if product has been frozen
Discard product if it contains particulate matter, is cloudy, or discolored
Do not freeze
NATPARA 25mcg Powder for Injection

Reported Side Effects for NATPARA 25mcg Powder for Injection

Infection Incidence:
<8.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Hypoesthesia Incidence:
6.0-14.0%*
Severity: MILD
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
6.0-10.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Antibody Formation Incidence:
8.6%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
11.0%*
Severity: MILD
Onset: DELAYED
High Urine Calcium Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
18.0%*
Severity: MILD
Onset: EARLY
High Calcium Levels Incidence:
19.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
25.0%*
Severity: MILD
Onset: EARLY
Low Calcium Levels Incidence:
27.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
31.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with NATPARA

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5